Leanne has just completed her DPhil in Chemical Biology at Oxford University. Her project used chemically synthesised saccharides to modify adenovirus, creating targeted viral vectors for DNA vaccination. Having studied Chemistry at undergraduate level, Leanne has relished the opportunity to venture into the field of immunology. Currently she is undertaking a PostDoc exploring chemical epitope shielding in protein vaccine design. Leanne is excited about the future of the chemistry-immunology interface and believes that strong collaboration between chemists and immunologists will yield the discoveries and therapies of the future. She is the current chair of the newly established Molecular Immunology affinity group (Mol.i.G) of the BSI.

Last updated: 05-03-16